Search the Library
NOTE: This is a new search platform (as of May 2026). If you do a search and don’t get the results you were expecting, please email us at ctnlib@uw.edu to let us know? (If possible, please share your exact search strategy. Thank you!)
Enter keywords and hit Enter (or click the magnifying glass) to search. You can then also select document type or subject/topic to narrow results further (or just use those for searching without a keyword). Results display below this search form.
Document types
Subjects
- CTN-#### format for protocols (CTN-0001, e.g.)
- “exact phrase” (if phrase is not found, it will return results that contain all terms
- word1 NOT word2
- word1 word2 (finds both words)
- Click title to access full-text
- “Show details” reveals abstract & other info
- Checkboxes select items for copy/pasting or printing
- Need help getting a copy of a journal article?
Email ctnlib@uw.edu
Search results
American Indian and Alaska Native (AI/AN) communities experience a disproportionate burden of substance use disorders (SUDs) alongside persistent barriers to culturally responsive care and research participation. Despite this need, AI/AN populations remain underrepresented in substance use research, in part due to historical and ongoing systemic inequities, including research practices that have not adequately respected Tribal sovereignty or incorporated Indigenous knowledge systems. This commentary synthesizes research conducted within the National Institute on Drug Abuse (NIDA) Clinical Trials Network (CTN) focused on AI/AN communities, identifies key lessons learned from this body of work, and offers recommendations for future research.
First, we provide an overview of CTN-supported studies involving AI/AN populations, highlighting both the diversity of substance use patterns across communities and the feasibility of conducting rigorous, culturally responsive research. Second, we synthesize lessons learned from these studies and related literature, including the importance of long-term relationship building, the need for culturally responsive research frameworks, structural barriers to implementation, and workforce and infrastructure challenges. Third, we present recommendations for the field, emphasizing the central role of community-based participatory research (CBPR) and Tribal participatory research (TPR), the integration of Indigenous knowledge systems, and the importance of Tribal data sovereignty and community-led dissemination.
Collectively, this commentary argues that sustainable progress in addressing SUDs among AI/AN populations requires a fundamental shift toward community-engaged, culturally responsive, and equity-focused research partnerships. The experiences of the CTN AI/AN Special Interest Group demonstrate that such approaches are not only feasible but essential for advancing both scientific knowledge and community health.
Related protocols: CTN-0020-A-1, CTN-0033-Ot-1, CTN-0033-Ot-2, CTN-0033-Ot-3, CTN-0033-Ot-4, CTN-0033-Ot-5, CTN-0044-A2, CTN-0078-Ot, CTN-0096, CTN-0096-A-1, CTN-0118, CTN-0123, CTN-0129
Community-university teams investigated substance use, abuse, and dependence (SUAD) and related concerns, needs, strengths, and resources in four Washington State Tribal communities as part of National Drug Abuse Treatment Clinical Trials Network (CTN) protocol CTN-0033-Ot-3.
One hundred and fifty-three key community members shared their perspectives through 45 semi-structured interviews and 19 semi-structured focus groups. Qualitative data analysis revealed robust themes: prescription medications and alcohol were perceived as most prevalent and concerning; family and peer influences and emotional distress were prominent perceived risk factors; and SUAD intervention resources varied across communities. Findings may guide future research and the development of much needed strength-based, culturally appropriate, and effective SUAD interventions for American Indians, Alaska Natives, and their communities.
Related protocols: CTN-0033-Ot-3
This is the Results Article for CTN-0033-Ot-3.
Qualitative and quantitative data and participatory research approaches might be most valid and effective for assessing substance use/abuse and related trends in American Indian and Alaska Native (AIAN) communities. In this study, protocol CTN-0033-Ot-3, 29 federally recognized AIAN tribes in Washington state were invited to participate in health directors interviews and state treatment admissions data analyses. Ten tribal health directors (or designees) from across WA participated in 30-60 minute qualitative interviews. State treatment admissions data from 2002-2008 were analyzed for those who identified with one of 11 participating AIAN communities to explore admission rates by primary drug compared to non-AIANs. Those who entered treatment and belonged to one of the 11 participating tribes (n=4851) represented 16% of admissions for those who reported a tribal affiliation. Interviewees reported that prescription drugs, alcohol, and marijuana are primary community concerns, each presenting similar and distinct challenges. Additionally, community health is tied to access to resources, services, and culturally appropriate and effective interventions. Treatment data results were consistent with interviewee-reported substance use/abuse trends, with alcohol as the primary drug for 56% of AIAN adults compared to 46% of non-AIAN, and other opiates as second most common for AIAN adults in 2008 with 15% of admissions.
Conclusions: Analyses suggest that some diverse AIAN communities in Washington state share similar substance use/abuse, treatment, and recovery trends and continuing needs. This study also demonstrated that appropriate and effective research with AIAN communities requires respectful and flexible approaches. It is of utmost importance to recognize that communities are engaged in many high priority endeavors to meet their members’ needs and ensure that research is a positive experience with tangible benefits for participating communities.
Related protocols: CTN-0033-Ot-3
The Methamphetamine and Other Drugs (MOD) in American Indian and Alaska Native communities (AIAN) project grew from NIDA?s commitment to reducing health disparities with a specific emphasis on a better understanding of the epidemiology and treatment of drug abuse, and its health consequences in minority populations in general, and AIAN communities in particular. Because few data exist on methamphetamine and other drug use in AIAN communities, NIDA’s National Drug Abuse Treatment Clinical Trials Network (CTN) funded several exploratory and developmental projects in order to develop collaborative research partnerships with AIAN communities. Each participating Node has specific processes in place for reporting and disseminating research findings that require Tribal approval from its respective research partners and findings from these projects will be presented in future publications and at professional meetings — in full partnership with our community research partners.
The purpose of this brief report is to describe the process followed by each of the Nodes as they have developed their research partnerships with AIAN communities; lessons learned and recommendations for others interested in ethical research with AIAN communities are also presented.
Related protocols: CTN-0033-Ot, CTN-0033-OT-1, CTN-0033-Ot-2, CTN-0033-Ot-3, CTN-0033-Ot-4, CTN-0033-Ot-5